Frank L. Douglas

Last updated

Frank L. Douglas
Born (1943-04-30) April 30, 1943 (age 80)
Georgetown, Guyana
Alma mater
  • Lehigh University (BS)
  • Cornell University (PhD, MD)
Scientific career
FieldsPharmaceuticals
Website freemanblackstream.com

Frank Lennox Douglas (born April 30, 1943) is a Guyanese-American biomedical researcher and business executive.

Contents

Education and career

Douglas was born April 30, 1943, in Georgetown, Guyana.[ citation needed ] He graduated with a BS in Engineering from Lehigh University in 1966. [1] He went on to a PhD in Physical Chemistry from Cornell University, which he received at the beginning of 1973, with a thesis on chlorophyll-a. [2] After a brief stint working at Xerox, [3] Douglas moved to New York City to pursue a medical degree from the Cornell University Medical School. [1] After finishing the MD, Douglas completed an internship and residency in internal medicine at Johns Hopkins Medical Institution, and a fellowship in neuroendocrinology at the National Institutes of Health. [1]

Following his fellowship, Douglas took a position as an assistant professor of medicine at the University of Chicago, in which role he remained for 5 years. [3] At this time, he also began work at the pharmaceutical company Ciba-Geigy. [3] In 1992, he moved as an executive vice president to Marion Merrell Dow, where he remained as it was acquired and changed names to Hoechst Marion Roussel, and later to Aventis. [3] [4] [ better source needed ]

In 2005, Douglas left Aventis and took a position as a professor of the practice at Massachusetts Institute of Technology, where he was involved in founding the Center for Biomedical Innovation. [3] [5] [6] After 2 years at MIT, he resigned over concerns about institutional racism, particularly regarding the tenure-denial of James Sherley. [5] [7] [8] [9]

In 2009, Douglas moved to Akron, Ohio, to serve as president and CEO of the Austen BioInnovation Institute. [10] [11] [12] He left the institute at the beginning of 2015. [10] [13]

Douglas published an autobiography in 2018, titled Defining Moments of a Free Man from a Black Stream.

Books

Honors and awards

Related Research Articles

<span class="mw-page-title-main">Akron, Ohio</span> City in Ohio, United States

Akron is a city in and the county seat of Summit County, Ohio, United States. At the 2020 census, the city proper had a total population of 190,469, making it the fifth-most populous city in Ohio and 136th-most populous city in the United States. The Akron metropolitan area, covering Summit and Portage counties, had a population of 702,219. It is located on the western edge of the Glaciated Allegheny Plateau in Northeast Ohio about 40 miles (64 km) south of downtown Cleveland.

<span class="mw-page-title-main">MIT Sloan School of Management</span> Business school of the Massachusetts Institute of Technology

The MIT Sloan School of Management is the business school of the Massachusetts Institute of Technology, a private university in Cambridge, Massachusetts. MIT Sloan offers bachelor's, master's, and doctoral degree programs, as well as executive education. Its degree programs are among the most selective in the world. MIT Sloan emphasizes innovation in practice and research. Many influential ideas in management and finance originated at the school, including the Black–Scholes model, the Solow–Swan model, the random walk hypothesis, the binomial options pricing model, and the field of system dynamics. The faculty has included numerous Nobel laureates in economics and John Bates Clark Medal winners.

<span class="mw-page-title-main">Robert S. Langer</span> American scientist

Robert Samuel Langer Jr. FREng is an American biotechnologist, businessman, chemical engineer, chemist, and inventor. He is one of the twelve Institute Professors at the Massachusetts Institute of Technology.

<span class="mw-page-title-main">Lionel Tarassenko</span> British engineer and academic

Lionel Tarassenko, is a British engineer and academic, who is a leading expert in the application of signal processing and machine learning to healthcare. Tarassenko is President of Reuben College, Oxford.

<span class="mw-page-title-main">Gordon Prize</span> Engineering award

The Bernard M. Gordon Prize was started in 2001 by the United States National Academy of Engineering. Its purpose is to recognize leaders in academia for the development of new educational approaches to engineering. Each year, the Gordon Prize awards $500,000 to the grantee, of which the recipient may personally use $250,000, and his or her institution receives $250,000 for the ongoing support of academic development. Although the Gordon Prize is relatively new, within engineering education, it is viewed by many to be the American equivalent of the Nobel Prize.

<span class="mw-page-title-main">John S. Knight</span> American newspaper publisher

John Shively Knight was an American newspaper publisher and editor based in Akron, Ohio.

Robert Allan Weinberg is a biologist, Daniel K. Ludwig Professor for Cancer Research at Massachusetts Institute of Technology (MIT), director of the Ludwig Center of the MIT, and American Cancer Society Research Professor. His research is in the area of oncogenes and the genetic basis of human cancer.

<span class="mw-page-title-main">Rudolf Jaenisch</span> German biologist

Rudolf Jaenisch is a Professor of Biology at MIT and a founding member of the Whitehead Institute for Biomedical Research. He is a pioneer of transgenic science, in which an animal’s genetic makeup is altered. Jaenisch has focused on creating genetically modified mice to study cancer, epigenetic reprogramming and neurological diseases.

Mehmet Toner is a Turkish biomedical engineer. He is currently the Helen Andrus Benedict Professor of Surgery at Massachusetts General Hospital (MGH) and Harvard Medical School, with a joint appointment as professor at the Harvard-MIT Division of Health Sciences and Technology (HST).

James Sherley is a biological engineer and the founder of Asymmetrex, an adult stem cell research center. He has also conducted research at the Boston Biomedical Research Institute and Massachusetts Institute of Technology (MIT). Sherley filed a suit against the government in Sherley v. Sebelius, resulting in a protracted legal battle attempting to ban the government from funding any research relating to embryonic stem cells.

David I. Kaiser is an American physicist and historian of science. He is Germeshausen Professor of the History of Science at the Massachusetts Institute of Technology (MIT) and a full professor in MIT's department of physics. He also served as an inaugural associate dean for MIT's cross-disciplinary program in Social and Ethical Responsibilities of Computing.

Alan Anthony Altshuler is an American educator and government official. Altshuler is the Ruth and Frank Stanton Professor in Urban Policy and Planning, Emeritus, at the Harvard University Graduate School of Design and the John F. Kennedy School of Government.

Elazer R. Edelman is an American engineer, scientist and cardiologist. He is the Edward J. Poitras Professor in Medical Engineering and Science at the Massachusetts Institute of Technology (MIT), Professor of Medicine at Harvard Medical School and at Brigham and Women's Hospital (BWH), and a practicing cardiologist at BWH. He is the director of MIT's Institute for Medical Engineering and Science (IMES), the Harvard-MIT Biomedical Engineering Center, and the MIT Clinical Research Center. He is also the Program Director of the MIT Graduate Education in Medical Sciences program within the Harvard-MIT Division of Health Sciences and Technology.

<span class="mw-page-title-main">Joachim Frank</span> German-born American biophysicist and Nobel laureate (born 1940)

Joachim Frank ; born September 12, 1940) is a German-American biophysicist at Columbia University and a Nobel laureate. He is regarded as the founder of single-particle cryo-electron microscopy (cryo-EM), for which he shared the Nobel Prize in Chemistry in 2017 with Jacques Dubochet and Richard Henderson. He also made significant contributions to structure and function of the ribosome from bacteria and eukaryotes.

<span class="mw-page-title-main">Krystyn Van Vliet</span> American engineer (born 1976)

Krystyn J. Van Vliet is vice president for research and innovation at Cornell University and a faculty member in the Cornell University College of Engineering, where she has a joint appointment in the Department of Materials Science and Engineering and the Meinig School of Biomedical Engineering. Her research lab specializes in material chemomechanics, the coupling between chemistry and mechanics at material interfaces.

Martha Gray is a biomedical engineer and professor at the Massachusetts Institute of Technology, jointly appointed in the Department of Electrical Engineering and Health Sciences and Technology (HST). Gray became the first woman to lead a department of science or engineering at MIT when she became the co-director of the Harvard–MIT Program of Health Sciences and Technology in 1987. She has developed multidisciplinary programs at MIT. Her research focuses on understanding and preventing Osteoarthritis, and her team developed the imaging technology dGEMRIC, now used to examine cartilage.

Richard Anthony Lewis JonesFInstP FLSW is professor of Materials Physics and Innovation Policy at the University of Manchester having been professor of physics at the University of Sheffield until 2020.

Tania S. Douglas was a Professor of Biomedical Engineering, Research Chair in Biomedical Engineering and Innovation as well as Director of the Medical Imaging Research Unit in the University of Cape Town (UCT), South Africa. She conducted research concerning medical innovation, image analysis, and the development of technologies to improve medical device innovation in South Africa. She was also the founding Editor-in-Chief of Global Health Innovation, a journal which disseminates research results about health innovation in developing settings.

Sina Y. Rabbany is the Jean Nerken Distinguished Professor of Engineering at Hofstra University, dean of the Fred DeMatteis School of Engineering and Applied Science, founding director of the school's Bioengineering program, and adjunct associate professor of bioengineering at the Weill Cornell Medical College of Cornell University. Under his tenure, the DeMatteis School's fast growth led to the school's planned expansion into a new Science and Innovation Center. His research concerns cellular and tissue engineering of the vascular system and investigates the impact of the biophysical microenvironment on the structure and function of endothelial cells. His research explores the capabilities of endothelial cells to build functional blood vessels and support organ regeneration. His h-index is 28 by Google Scholar.

References

  1. 1 2 3 "Frank L. Douglas". Engineering. Alumni Heritage Initiative. Lehigh University. Retrieved January 6, 2021.
  2. ↑ Douglas, Frank Lennox (January 1973). Some photoelectric properties of chlorophyll-a aggregates (PhD thesis). Cornell University.
  3. 1 2 3 4 5 "About / Curriculum Vitae". Frank L. Douglas. Retrieved January 7, 2021.
  4. ↑ "The End (and the Beginning) is Near". Forbes. August 22, 1999. Retrieved January 20, 2021.
  5. 1 2 Bhattacharjee, Yudhijit (June 8, 2007). "News of the Week | MIT Colleague Quits to Protest Sherley Dismissal". Science . 316 (5830): 1405. doi: 10.1126/science.316.5830.1405 . PMID   17556555. S2CID   153467729.
  6. ↑ "People - Frank L. Douglas, Ph.D., M.D." MIT Center for Biomedical Innovation. Archived from the original on March 26, 2007. Retrieved August 12, 2008.
  7. ↑ Smallwood, Scott (June 4, 2007). "MIT Professor Resigns to Protest Treatment of Hunger-Striking Colleague". The Chronicle of Higher Education. Retrieved January 7, 2021.
  8. ↑ Schworm, Peter (June 4, 2007). "MIT Center Director Resigns In Protest Of Tenure Decision". Boston Globe. Retrieved January 7, 2021.
  9. ↑ Schaffer, Amanda (October 20, 2020). "The long path to inclusivity". MIT Technology Review . Retrieved January 19, 2021.
  10. 1 2 "Akron BioInnovation Institute's leader stepping down at end of year". Akron Beacon Journal. November 26, 2014. Retrieved January 19, 2021.
  11. ↑ Douglas, F. (2009). "An Audience With | Frank Douglas". Nature Reviews Drug Discovery. Springer Science and Business Media LLC. 8 (11): 840. doi: 10.1038/nrd3047 . ISSN   1474-1776. PMID   19876037. S2CID   6930338.
  12. 1 2 "Dr. Frank Douglas". Akron Life. January 10, 2011. Retrieved January 8, 2021.
  13. ↑ Soder, Chuck (October 25, 2015). "Austen BioInnovation Institute shrinks, regroups". Crain's Cleveland Business. Retrieved January 7, 2021.
  14. ↑ Reviews of Defining Moments of a Free Man from a Black Stream:
  15. ↑ Maxmen, Amy (November 16, 2010). "Scientists as rock stars?". The Scientist. Retrieved January 7, 2021.
  16. ↑ "Douglas receives Black History Maker award". MIT News. Massachusetts Institute of Technology. March 26, 2007.
  17. ↑ "Verleihung von Ehrendoktorwürde, Fachbereichsplakette und Promotionspreis" (PDF). Uni-Klinik Aktuell. Goethe University Frankfurt. 2004. Retrieved January 7, 2021.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.